These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 24071691

  • 1. [Effect of calcitriol on secondary hyperparathyroidism].
    Xu H, Zhang J, Cheng X, Zhou Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691
    [Abstract] [Full Text] [Related]

  • 2. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y, Ding F, Chen N, Mei CL, Qian JQ, Wang XY, Shi W, Hou FF, Li XW, Wang M, Chen YP.
    Ren Fail; 2005 Sep; 27(2):205-12. PubMed ID: 15807187
    [Abstract] [Full Text] [Related]

  • 3. [Effect of cinacalcet combined with low-dose calcitriol on clinical outcome and bone metabolism in patients with severe secondary hyperparathyroidism].
    Yuan F, Chen X, Wang C, Zhou A, Liu H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct 28; 42(10):1169-1173. PubMed ID: 29093248
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of small doses of calcitriol in hemodialysis patients with moderate secondary hyperparathyroidism.
    Vlassopoulos D, Noussias C, Revenas K, Hadjilouka-Mantaka A, Arvanitis D, Tzortzis G, Hadjiconstantinou V.
    Ren Fail; 1999 Mar 28; 21(2):199-207. PubMed ID: 10088180
    [Abstract] [Full Text] [Related]

  • 5. Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients With Low Bone Mass.
    Chen CL, Chen NC, Liang HL, Hsu CY, Chou KJ, Fang HC, Lee PT.
    J Clin Endocrinol Metab; 2015 Jul 28; 100(7):2784-92. PubMed ID: 25955225
    [Abstract] [Full Text] [Related]

  • 6. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism.
    Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK.
    Am J Kidney Dis; 1999 Jan 28; 33(1):73-81. PubMed ID: 9915270
    [Abstract] [Full Text] [Related]

  • 7. Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism.
    Ong LM, Narayanan P, Goh HK, Manocha AB, Ghazali A, Omar M, Mohamad S, Goh BL, Shah S, Seman MR, Vaithilingam I, Ghazalli R, Rahmat K, Shaariah W, Ching CH, Oral Paricalcitol in ESRD Study Group.
    Nephrology (Carlton); 2013 Mar 28; 18(3):194-200. PubMed ID: 23311404
    [Abstract] [Full Text] [Related]

  • 8. Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.
    Zheng CM, Wu CC, Hung CF, Liao MT, Shyu JF, Hsu YH, Lu CL, Wang YH, Zheng JQ, Chang TJ, Lin YF, Lu KC.
    Nutrients; 2018 Feb 10; 10(2):. PubMed ID: 29439405
    [Abstract] [Full Text] [Related]

  • 9. Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial.
    Ito H, Ogata H, Yamamoto M, Takahashi K, Shishido K, Takahashi J, Taguchi S, Kinugasa E.
    Clin Nephrol; 2009 Jun 10; 71(6):660-8. PubMed ID: 19473635
    [Abstract] [Full Text] [Related]

  • 10. Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism.
    Llach F, Yudd M.
    Am J Kidney Dis; 2001 Nov 10; 38(5 Suppl 5):S45-50. PubMed ID: 11689387
    [Abstract] [Full Text] [Related]

  • 11. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
    Reichel H.
    Nephron Clin Pract; 2010 Nov 10; 114(4):c268-76. PubMed ID: 20090369
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study.
    Tonbul HZ, Solak Y, Atalay H, Turkmen K, Altintepe L.
    Ren Fail; 2012 Nov 10; 34(3):297-303. PubMed ID: 22251408
    [Abstract] [Full Text] [Related]

  • 13. [Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study].
    Mpio I, Boumendjel N, Karaaslan H, Arkouche W, Lenz A, Cardozo C, Cardozo J, Pastural-Thaunat M, Fouque D, Silou J, Attaf D, Laville M.
    Nephrol Ther; 2011 Jul 10; 7(4):229-36. PubMed ID: 21353659
    [Abstract] [Full Text] [Related]

  • 14. Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase technetium Tc 99m-sestamibi scintigraphy.
    Torregrosa JV, Fuster D, Ybarra J, Ortín J, Moreno A, Valveny N.
    Am J Kidney Dis; 2004 Sep 10; 44(3):476-80. PubMed ID: 15332220
    [Abstract] [Full Text] [Related]

  • 15. Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Akizawa T, Akiba T, Hirakata H, Kinugasa E, Tominaga Y, Fukagawa M, Yokoyama K, Zhang W, Linde PG, Suzuki M.
    Ther Apher Dial; 2015 Jun 10; 19(3):225-34. PubMed ID: 25363733
    [Abstract] [Full Text] [Related]

  • 16. Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients: Responsiveness is related to parathyroid gland size.
    Vulpio C, Maresca G, Distasio E, Cacaci S, Panocchia N, Luciani G, Bossola M.
    Hemodial Int; 2011 Jan 10; 15(1):69-78. PubMed ID: 21223484
    [Abstract] [Full Text] [Related]

  • 17. Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism.
    Jamaluddin EJ, Gafor AH, Yean LC, Cader R, Mohd R, Kong NC, Shah SA.
    Clin Exp Nephrol; 2014 Jun 10; 18(3):507-14. PubMed ID: 23903802
    [Abstract] [Full Text] [Related]

  • 18. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S, Wazny LD, Martin JE.
    Can J Clin Pharmacol; 2008 Jun 10; 15(1):e36-43. PubMed ID: 18192704
    [Abstract] [Full Text] [Related]

  • 19. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage.
    Grekas D, Balaskas E, Kampouris H, Benos A, Konstantinou A, Sioullis A, Tourkantonis A.
    Clin Nephrol; 1999 Sep 10; 52(3):167-71. PubMed ID: 10499312
    [Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 10; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.